Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine

By Boursaux-Eude C.   Thiberge S.   Carletti G.   Guiso N.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2651-2660

Elsevier

Access to resources Recommend Favorite

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

By Heath D.G.   Anderson G.W.   Mauro J.M.   Welkos S.L.   Andrews G.P.   Adamovicz J.   Friedlander A.M.  

Vaccine, Vol. 16, Iss. 11, 1998-07 ,pp. : 1131-1137

Elsevier

Access to resources Recommend Favorite

Candidate peptide vaccine induced protection against classical swine fever virus

By Dong X.-N.   Wei K.   Liu Z.-Q.   Chen Y.-H.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

By Baca-Estrada M.E.M.E.   Foldvari M.M.   Snider M.M.   Harding K.K.   Kournikakis B.B.   Babiuk L.A.L.A.   Griebel P.P.  

Vaccine, Vol. 18, Iss. 21, 2000-04 ,pp. : 2203-2211

Elsevier

Access to resources Recommend Favorite

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

By Eyles J.E.   Sharp G.J.E.   Williamson E.D.   Spiers I.D.   Alpar H.O.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 698-707

Elsevier

Access to resources Recommend Favorite